Statins inhibit A beta-neurotoxicity in vitro and A beta-induced vasoconstriction and inflammation in rat aortae (Q43912948)

28 November 2017

title

Statins inhibit A beta-neurotoxicity in vitro and A beta-induced vasoconstriction and inflammation in rat aortae (English)

1 reference

28 November 2017

1 reference

1 reference

1 reference

28 November 2017

Demian F Obregon

1 reference

28 November 2017

Daniel Paris

1 reference

28 November 2017

Kirk P Townsend

series ordinal

1 reference

28 November 2017

James Humphrey

series ordinal

1 reference

28 November 2017

Kiyoko Yokota

series ordinal

1 reference

28 November 2017

publication date

1 April 2002

1 reference

28 November 2017

1 reference

28 November 2017

volume

161

1 reference

28 November 2017

1 reference

28 November 2017

page(s)

293-299

1 reference

28 November 2017

cites work

The Alzheimer diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900660-8

Brain microvascular changes in Alzheimer's disease and other dementias.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900660-8

Microvascular pathology and vascular basement membrane components in Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900660-8

The role of cerebral ischemia in Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900660-8

Regional cerebral blood flow single-photon emission tomography with 99mTc-HMPAO and the acetazolamide test in the evaluation of vascular and Alzheimer's dementia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900660-8

Preclinical prediction of Alzheimer's disease using SPECT.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900660-8

Vascular risk factors for Alzheimer's disease: an epidemiologic perspective.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900660-8

Atherosclerosis, apolipoprotein E, and prevalence of dementia and Alzheimer's disease in the Rotterdam Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900660-8

Diabetes mellitus and the risk of dementia: The Rotterdam Study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900660-8

Smoking and risk of dementia and Alzheimer's disease in a population-based cohort study: the Rotterdam Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900660-8

Dietary fat intake and the risk of incident dementia in the Rotterdam Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900660-8

15-year longitudinal study of blood pressure and dementia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900660-8

Coronary Artery Disease, Hypertension, ApoE, and Cholesterol: A Link to Alzheimer's Disease?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900660-8

Cholesterol modulates vascular reactivity to endothelin-1 by stimulating a pro-inflammatory pathway.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900660-8

Native Nicotinic Acetylcholine Receptors in Human Imr32 Neuroblastoma Cells: Functional, Immunological and Pharmacological Properties

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900660-8

Rapid and substantial lowering of human serum cholesterol by mevinolin (MK-803), an inhibitor of hydroxymethylglutaryl-coenzyme A reductase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900660-8

Anti-amyloidogenic activity of tetracyclines: studies in vitro.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900660-8

Stimulation of bone formation in vitro and in rodents by statins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900660-8

Lovastatin augments sulindac-induced apoptosis in colon cancer cells and potentiates chemopreventive effects of sulindac

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900660-8

Statins and the risk of dementia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900660-8

Decreased prevalence of Alzheimer disease associated with 3-hydroxy-3-methyglutaryl coenzyme A reductase inhibitors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900660-8

The role of cholesterol in the biosynthesis of beta-amyloid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900660-8

Intraneuronal beta-amyloid immunoreactivity in the CNS.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900660-8

Relative Lipophilicities, Solubilities, and Structure–Pharmacological Considerations of 3-Hydroxy-3-Methylglutaryl-Coenzyme A (HMG-CoA) Reductase Inhibitors Pravastatin, Lovastatin, Mevastatin, and Simvastatin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900660-8

Tissue-selective inhibition of cholesterol synthesis in vivo by pravastatin sodium, a 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900660-8

HMG-CoA reductase inhibitor induces a transient activation of high affinity nerve growth factor receptor, trk, and morphological differentiation with fatal outcome in PC12 cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900660-8

Geranylgeranyl-pyrophosphate, an isoprenoid of mevalonate cascade, is a critical compound for rat primary cultured cortical neurons to protect the cell death induced by 3-hydroxy-3-methylglutaryl-CoA reductase inhibition.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900660-8

10.1016/S0021-9150(01)00660-8

7 January 2021

Identifiers

DOI

1 reference

28 November 2017

1 reference